09/14/2026
Type 2 diabetes appears to leave a measurable metabolic fingerprint in the blood years before diagnosis.
Researchers combined metabolomic, genetic, and lifestyle data from 23,634 adults across 10 prospective cohorts, all free of diabetes at baseline and followed for up to 26 years. Of 469 circulating metabolites, 235 were associated with future type 2 diabetes, including 67 associations not previously reported. Those signals spanned bile acids, lipids, carnitines, amino-acid pathways, and other aspects of energy metabolism.
The investigators then built a 44-metabolite signature. When that signature was added to a conventional risk model containing factors such as age, s*x, BMI, smoking, hypertension, dyslipidemia, medications, and family history, prediction of future diabetes improved across the testing cohorts. The exact improvement varied by cohort, which is why this should not be reduced to one universal AUC number.
The most useful part may be what shaped the metabolite pattern. Physical activity, obesity, and diet explained more variation in the diabetes-associated metabolites than in metabolites that did not predict diabetes. That does not prove lifestyle changes work by altering these specific molecules, but it suggests that the metabolic signature is not simply a fixed genetic fingerprint.
For now, this is research rather than a clinical blood test. But it illustrates where diabetes prediction may be heading: away from relying on one glucose measurement or one risk factor and toward patterns that capture several biological pathways at once.
Maintain a healthy body composition, stay physically active, and build a diet around high-quality minimally processed foods. The technology may become more sophisticated, but many of the biological signals it detects still appear connected to modifiable behaviors.
Li J, et al. Nature Medicine. 2026. PMID: 41535386.
